Gissmann L - Search Results

1

Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.

Müller M, Viscidi RP, Sun Y, Guerrero E, Hill PM, Shah F, Bosch FX, Muñoz N, Gissmann L, Shah KV. Müller M, et al. Among authors: gissmann l. Virology. 1992 Apr;187(2):508-14. doi: 10.1016/0042-6822(92)90453-v. Virology. 1992. PMID: 1312268

2

Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination.

Michel N, Osen W, Gissmann L, Schumacher TN, Zentgraf H, Müller M. Michel N, et al. Among authors: gissmann l. Virology. 2002 Mar 1;294(1):47-59. doi: 10.1006/viro.2001.1321. Virology. 2002. PMID: 11886264 Free article.

3

Development of prophylactic HPV vaccines.

Gissmann L, Müller M. Gissmann L, et al. Coll Antropol. 2007 Apr;31 Suppl 2:113-5. Coll Antropol. 2007. PMID: 17598512 Review.

4

Antibodies to human papillomavirus type 11 virus-like particles in sera of patients with genital warts and in control groups.

Eisemann C, Fisher SG, Gross G, Müller M, Gissmann L. Eisemann C, et al. Among authors: gissmann l. J Gen Virol. 1996 Aug;77 ( Pt 8):1799-803. doi: 10.1099/0022-1317-77-8-1799. J Gen Virol. 1996. PMID: 8760429

5

Identification of seroreactive regions of the human papillomavirus type 16 protein E4, E6, E7 and L1.

Müller M, Gausepohl H, de Martynoff G, Frank R, Brasseur R, Gissmann L. Müller M, et al. Among authors: gissmann l. J Gen Virol. 1990 Nov;71 ( Pt 11):2709-17. doi: 10.1099/0022-1317-71-11-2709. J Gen Virol. 1990. PMID: 1701482

6

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.

Ohlschläger P, Osen W, Dell K, Faath S, Garcea RL, Jochmus I, Müller M, Pawlita M, Schäfer K, Sehr P, Staib C, Sutter G, Gissmann L. Ohlschläger P, et al. Among authors: gissmann l. J Virol. 2003 Apr;77(8):4635-45. doi: 10.1128/jvi.77.8.4635-4645.2003. J Virol. 2003. PMID: 12663770 Free PMC article.

7

Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells.

Mossadegh N, Gissmann L, Müller M, Zentgraf H, Alonso A, Tomakidi P. Mossadegh N, et al. Among authors: gissmann l. Virology. 2004 Aug 15;326(1):57-66. doi: 10.1016/j.virol.2004.04.050. Virology. 2004. PMID: 15262495 Free article.

8

Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1.

Kuck D, Lau T, Leuchs B, Kern A, Müller M, Gissmann L, Kleinschmidt JA. Kuck D, et al. Among authors: gissmann l. J Virol. 2006 Mar;80(6):2621-30. doi: 10.1128/JVI.80.6.2621-2630.2006. J Virol. 2006. PMID: 16501072 Free PMC article.

9

A long way: history of the prophylactic papillomavirus vaccine.

Müller M, Gissmann L. Müller M, et al. Among authors: gissmann l. Dis Markers. 2007;23(4):331-6. doi: 10.1155/2007/939634. Dis Markers. 2007. PMID: 17627066 Free PMC article. Review. No abstract available.

10

Enhanced papillomavirus-like particle production in insect cells.

Senger T, Schädlich L, Gissmann L, Müller M. Senger T, et al. Among authors: gissmann l. Virology. 2009 Jun 5;388(2):344-53. doi: 10.1016/j.virol.2009.04.004. Epub 2009 May 1. Virology. 2009. PMID: 19409593 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters